Dr. Basu will lead the organization’s commitment to advancing patient care and education C. Bob Basu, MD, MBA, MPH, FACS C.

The US FDA has granted breakthrough therapy designation (BTD) to the bifunctional antibody ficerafusp alfa (BCA101) in ...

CMS Administrator Mehmet Oz, MD, MBA, said his agency will make an announcement on potential Medicare coverage of GLP-1 ...

Shawn Griffin, a former family physician who moved into chief medical information officer and related leadership roles in ...

Ficci announces RPG Group's Anant Goenka as President-Elect for 2025-26, succeeding Harsha Vardhan Agarwal at annual meeting.

University of Maryland students now qualify for guaranteed interviews at MSOM through a new partnership and pre-med support program.

Dr. Rubin adds that oral minoxidil may offer more consistent absorption and better results for some patients compared to topical minoxidil. “Topical minoxidil tends to have fewer systemic effects and ...

DURAVYU now in Phase 3 for the two largest, multi-billion-dollar retinal disease markets, wet AMD and DME with first patient dosing in pivotal Phase 3 DME trials anticipated in Q1 2026 – – New ...

Deepak Thakur appointed as Managing Director & CEO of Hinduja Renewables Energy, bringing 30 years of renewable energy ...

The appointment of the new MD and CEO comes at a time when the Hinduja Group is making a big push into clean energy with a ...